搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Lancashire Evening Post
16 分钟
Cancer treatment hearing loss study wins funding to launch
A study investigating whether a lesser known and under-reported side-effect of some chemotherapy medicines has a greater ...
Labroots
1 天
Scientists Discover Mechanism Behind Cancer Treatment Side Effects
Cancer is a disease in which mutated cells grow rapidly and uncontrollably. Unfortunately, these cells resist the body’s ...
1 天
‘There have been some really hard stretches’: Mike Lowe reflects on his cancer fight
It has been a long journey for WGN’s Mike Lowe in his cancer fight. In part four of the series, he talks about the road so ...
precisionmedicineonline
1 天
Despite Overall Survival Miss, Singapore Researchers Champion Success of Global Cell ...
The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...
Interesting Engineering on MSN
1 天
Gold-based drug slows cancer tumor growth by 82%, outperforms chemotherapy
A groundbreaking study by researchers from RMIT University in Australia and Indian institutions has unveiled a novel ...
1 天
Gold beats platinum for chemo drugs in new lab study
A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy ...
Endocrinology Advisor
2 天
Serum Lipid Profiles May Have Diagnostic Utility in Gastric Cancer
Serum lipid profile evaluation significantly improves diagnosis for gastric cancer and predictions for chemotherapy side effect outcomes.
EurekAlert!
2 天
Mayo Clinic
Mayo Clinic Comprehensive Cancer Center experts highlight breast cancer research that may reduce or eliminate the need for chemotherapy and endocrine treatments and may allow for shorter and less ...
Cure Today
2 天
Itovebi Combo May Improve Survival in Metastatic Breast Cancer Subtype
An Itovebi regimen demonstrated significantly longer progression-free survival compared with placebo in some with metastatic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈